행사/교육
Back to Pharmacology: Stem Cells & Primary Cells in Drug Discovery
- 등록일2007-10-22
- 조회수2567
- 구분 국외
- 행사교육분류 행사
-
주관기관
The Society for Biomolecular Sciences
-
행사장소
Anaheim Marriott Hotel
-
행사기간
2007-11-07 ~ 2007-11-08
- 원문링크
-
첨부파일
Back to Pharmacology: Stem Cells & Primary Cells in Drug Discovery
Meeting Information
Location : Anaheim Marriott Hotel
Address : 700 West Convention Way
City: Anaheim, CA 92802
Country : United States
Telephone : (203) 743-1336
FAX : (203) 748-7557
Email : mmanoni@sbsonline.org
Website : www.sbsonline.org
Meeting Sponsor Information
Company : The Society for Biomolecular Sciences
Contact : Marietta Manoni
Telephone : (203) 743-1336
Email : mmanoni@sbsonline.org
Description of the Event :
Join SBS for an exciting two-day symposium, featuring top-tier presentations, an Exhibit Hall and Networking Reception. This meeting will provide an overview of the use of both primary cells and stem cells in high-throughput screening and the drug-discovery process. Presentation topics will include: the influence of cell phenotype on pharmacology; practicalities of using primary and stem cells for high-throughput screening; comparing primary cells and engineered cells as tools for ADMET; the use of stem cells for target validation; and reconstituted multi-cellular in vitro systems.
Who should attend?
• Managers of HTS & target validation groups
• Assay development scientists
• Academics associated with screening centers
• Anyone interested in the use of primary and stem cells
for validation and screening (especially suppliers and service providers)
Everybody wins with SBS
Attendees gain up-to-date knowledge on the use of primary and stem cells screening. Participants can continue the dialogue and make connections during meal breaks and at the Networking Reception.
Exhibitors have the opportunity to gain new customers from diverse markets while also providing long-standing customers the chance to reconnect.
Sponsors benefit from high-level visibility in a growing customer base.
Special focus will center on a networking reception and meal functions planned to encourage strategy sharing and solution exploring in a smaller, more personal setting. The usual high-trafficked area of scientific posters will share novel approaches to industry challenges. And an SBS event would not be complete without an exciting exhibit hall (limited to only 30 life science innovators).
Poster presentations are limited to only 20 on a first-come, first-served basis. One poster is allowed per registered attendee or exhibiting company, based on availability. Reserve a poster stand when you register online. Posters will be displayed throughout the meeting rooms and registration area, and attendees can view them during breaks and during exhibition hours. (NOTE: to have title and author listed in the final program, you must register before September 17, 2007 at noon, EST and reserve a place for your poster.
Invited speakers include the following
3-D Co-culturing of Multiple Primary Cells for Drug Discovery, Diagnostics & Devices • Dawn Applegate, RegeneMed. Inc., USA
Human Embryonic Stem Cells - Applications for Drug Discovery & Medical Treatment • Veit Bergendahl, University of Wisconsin, USA
Functional Tissue Engineering for Musculoskeletal Tissue Repair Using Autogenous Mesenchymal Stem Cells • David Butler, University of Cincinnati, USA
Rewiring GPCR Signaling in Stem Cells & Mice; Dissection, Design & Construction • Bruce Conklin, Gladstone Institutes, UCSF, USA
Chemical & Functional Genomic Approaches Toward Regenerative Medicine Sheng Ding, Scripps Research Institute, USA
Heterotrimeric G proteins: How Your Cell Type Can Make Difference in GPCR Signaling • Annette Gilchrist, Caden Bioscience, USA
Using Primary Cells for HTS Follow-up in a Physiologically Relevant System • Eric Johnson, Merck, USA
Human Primary Cell-Based in vitro Experimental Systems for the Evaluation of Human Drug Safety • Albert Li, The ADMET Group LLC, USA
Applications of Stem Cells to Target Validation in Drug Development • Dan Marshak, PerkinElmer, USA
Stem Cells: Applications & Opportunities in Modern Drug Discovery (Plenary) • John McNeish, Pfizer, USA
Influence of Cell Phenotype on Pharmacology (Plenary) • Robert Pacifici, CHDI, USA
Nuclear Receptor Activation: Comparison Between Primary Hepatocytes & • Engineered Cell Lines • Judy Raucy, Puracyp, Inc., USA
Embryonic Stem Cells: Systems for Drug Discovery & Development • Ralph Snodgrass, VistaGen Therapeutics, Inc.
*Speakers and topics as of 2-25-07, subject to change.
Stay up-to-date with program details by visiting www.sbsonline.org.